Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Skolnik, Neil
One or more keywords matched the following items that are connected to
Skolnik, Neil
Item Type
Name
Concept
Blood Glucose
Concept
Blood Glucose Self-Monitoring
Academic Article
Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline.
Academic Article
When basal insulin is not enough: response to M Davidson.
Academic Article
When basal insulin is not enough: A dose-response relationship between insulin glargine 100 units/mL and glycaemic control.
Academic Article
Treatment of Type 1 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes.
Academic Article
Practical guidance for use of oral semaglutide in primary care: a narrative review.
Academic Article
Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies.
Academic Article
Efficacy and safety of insulin glargine/lixisenatide (iGlarLixi) fixed-ratio combination in older adults with type 2 diabetes.
Academic Article
Dapagliflozin in the treatment of patients with type 2 diabetes presenting with high baseline A1C.
Academic Article
Diabetes Technology: Review of the 2019 American Diabetes Association Standards of Medical Care in Diabetes.
Academic Article
Optimizing Insulin Therapy: Basal Insulin and Beyond.
Academic Article
Efficacy of iGlarLixi in adults with type 2 diabetes inadequately controlled (glycated haemoglobin =8%, =64?mmol/mol) on two oral antidiabetes drugs: Post hoc analysis of the LixiLan-O randomized trial.
Academic Article
iGlarLixi, a titratable once-daily fixed-ratio combination of basal insulin and lixisenatide for intensifying type 2 diabetes management for patients inadequately controlled on basal insulin with or without oral agents.
Search Criteria
Blood Glucose